A survey into toxic shock syndrome (TSS) in UK burns units

Burns

Volumn 26, Issue 4, 2000, Pages 323-333

  Edwards Jones, V ^a   Dawson, M M ^a   Childs, C ^b  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

Burn dressings; Toxic shock syndrome; Toxin mediated disease; Wound infections

Indexed keywords

CHLORHEXIDINE ACETATE; CHLORHEXIDINE GLUCONATE; FLAMMACERIUM; HYPOCHLORITE; POVIDONE IODINE; PSEUDOMONIC ACID; SODIUM CHLORIDE; SULFADIAZINE SILVER;

ARTICLE; BANDAGE; BURN; BURN INFECTION; HUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOXIC SHOCK SYNDROME; UNITED KINGDOM; WOUND CARE; WOUND DRESSING;

ADULT; AGE FACTORS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIBIOTIC PROPHYLAXIS; BANDAGES; BURNS; CHILD; CHILD, PRESCHOOL; DETERGENTS; GREAT BRITAIN; HUMANS; INCIDENCE; PATIENT ADMISSION; POVIDONE-IODINE; QUESTIONNAIRES; SHOCK, SEPTIC; SILVER SULFADIAZINE; SODIUM CHLORIDE; WOUND INFECTION;

EID: 0034114610     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(99)00142-4     Document Type: Article

References (32)

1. Frame J.D., Eve M.D., Hackett M.E.J., Dowsett E.G., Br ain A.N., Gault D.T., Wilmshurst A.D. The toxic shock syndrome in burned children. Burns. 11:1985;234-241.
2. Farmer B.A., Bradley J.S., Smiley P.W. Toxic shock syndrome in a scald burn victim. J. Trauma. 25:1985;1004.
3. Egan W.C., Clark W.R. The toxic shock syndrome in a burned victim. Burns. 14:1988;135.
4. McAllister R.M.R., Mercer N.S.G., Mercer B.D.G., Sanders R. Early diagnosis of staphylococcal toxaemia in burned children. Burns. 19:1993;22-25.
5. Childs C., Edwards-Jones V., Heathcote D.M., Dawson M., Davenport P. Patterns of Staphylococcus aureus colonisation, toxin production, immunity and illness in burned children. Burns. 20:1994;514-521.
6. Lawrence J.C. Burn bacteriology during the last 50 years. Burns. 2:(Suppl. 2):1994;S23-S29.
7. Edwards-Jones V., Childs C., Foster H.A. A comparison of phenotypic properties of isolates of S. aureus from burned patients and other patient groups. Burns. 22:1996;384-389.
8. Todd JK, Fishalt M, Kapral F, Welch T. Toxic shock syndrome associated with phage group 1 staphylococci. Lancet 1978, pp. 1116-8.
9. Edwards-Jones V., Foster H.A. The effect of antimicrobial agents on the production of toxic shock syndrome toxin-1 toxin. J. Med. Microbiol. 41:1994;505-509.
10. Edwards-Jones V. Toxic shock syndrome toxin production associated with burned children. Ph.D. thesis, Salford University, UK, 1997.
11. Weinzweig J., Gottilieb L.B., Krizek T.I. Toxic shock syndrome associated with the use of Biobrane in a scald burn victim. Burns. 20:1994;180-181.
12. Marrack P., Kappler J. The staphylococcal enterotoxins and relatives. Science. 248:1990;705-711.
13. Fleischer B. Superantigens. Behring Inst. Mitt. 94:1994;104-112.
14. Marples R.R., Weineke A.A. Toxic shock syndrome and related conditions in the United Kingdom 1992-1993. Comm. Dis. Rep. 4:1994;R1.
15. Yagoob M., McClelland P., Murray A.E., Mostafa S.M., Ahmad R. Staphylococcal enterotoxins A and C causing toxic shock syndrome. J. Infect. 20:1990;176-178.
16. Iandolo J.J. Genetic analysis of extracellular toxins of S. aureus. Annu. Rev. Microbiol. 43:1989;375-402.
17. Roggiani M., Schlievert P.M. Streptococcal toxic shock syndrome including necrotising fasciitis and myositis. Curr. Opin. Infect. Dis. 7:1994;423-426.
18. Willems C.E.D., Jones B., Matthew D.J. Pseudomonal toxic shock syndrome. Lancet. 2:1986;1218-1219.
19. Chesney P.J., Davis J.P., Purdy W.K., Wand P.J., Chesney R.W. Clinical manifestations of toxic shock syndrome. JAMA. 246:1981;741-748.
20. Moir G.C., Childs C., Shakespeare P.G. Early diagnosis of staphylococcal toxaemia. Burns. 19:1993;251. [letter to the editor].
21. Vergeront J.M., Stolz S.J., Crass B.A., Nelson D.B., Davis J.P., Bergdoll M.S. Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic shock syndrome. J. Infect. Dis. 148:1983;692-698.
22. Musser J.M., Schlievert P.M., Chow A.W., Ewan P., Kreiswirth B.N., Rosdahl V.T., Naidu A.S., Witte W., Selander R.K. A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc. Natl. Acad. Sci. USA. 87:1990;225-229.
23. Wong A.C.L., Bergdoll M.S. Effect of environmental conditions on production of toxic shock syndrome toxin 1 by Staphylococcus aureus. Infect. Immun. 58:1990;1026-1029.
24. Mills J.T., Parsonnet J., Tsai Y.C., Kendrick M., Hickman R.K., Kass E.H. Control of production of toxic shock syndrome toxin1 (TSST1) by magnesium ion. J. Infect. Dis. 151:1985;1158-1161.
25. Schlievert P.M., Deringer J.R., Kim M.H., Projan S.J., Novick R.P. Effect of glycerol monolaurate on bacterial growth and toxin production. Antimicrob. Agents Chem. 36:(3):1992;626-631.
26. Reeves M.W. Effect of trace metals on the synthesis of toxic shock syndrome toxin-1. Rev. Infect. Dis. 11:(Suppl. 1):1989;145-150.
27. Schlievert P.M., Blomster D.A., Kelly J.A. Effect of tampons on growth and production of TSS exotoxin. Obstet. Gynecol. 64:1984;666-674.
28. Papini R.P.G., Wilson A.P.R., Steer J.A., McGrowther B.A., Parkhouse N. Wound management in burn centres in the United Kingdom. Br. J. Surg. 82:1995;505-509.
29. Gel and colloid dressings. In: British National formulary, 28. London: British Medical Association and the Royal Pharmaceutical Society of Great Britain, 1994. p. 464-5.
30. Schrock C.G. Disease alert. JAMA. 243:1980;1231.
31. Andrews MM, Giacobbe KD, Parsonnet J. Induction of toxic shock syndrome toxin-1 (TSST-1) and beta-lactamase by subinhibitory concentrations of beta-lactam antibiotics (abstract). Biomedicine (1996), Washington DC, May 3-6, 1996, N-IN-0011.
32. Schlievert P.M., Kelly J.A. Clindamycin induced suppression of toxic shock syndrome associated exotoxin production. J. Infect. Dis. 149:1984;471-474.